Twist Bioscience (NASDAQ:TWST) is a company at the forefront of synthetic biology and DNA synthesis technology. With an innovative approach to manufacturing synthetic DNA, they cater to a wide range of industries, including biopharmaceuticals, agriculture, and industrial chemicals. Twist Bioscience leverages its high-throughput DNA synthesis platform to drive advancements in drug discovery, genetic research, and biosecurity. The company's objectives encompass improving the scalability, accuracy, and speed of synthetic DNA production to empower scientists and researchers around the globe. Through their efforts, Twist Bioscience aims to address critical global challenges by enabling sustainable bio-based solutions and advancing healthcare innovations.